3rd Annual Formulation & Drug Delivery Congress 2017

Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

Over 40 presentations and case studies focused on the key issues in biologics and small molecule drug formulation and delivery

4 interactive streams:

  • Large Molecule Drugs Formulation
  • Small Molecule Drug Delivery
  • Small Molecule Drugs Formulation
  • Large Molecule Drug Delivery

Co-located with the inaugural Inhalation & Respiratory Drug Delivery Congress covering the development and formulation of inhaled therapies and inhalation devices and analytics

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to announce the 3rd Annual Formulation & Drug Delivery Congress, taking place on the 22-23 May 2017 in London, UK. Our highly anticipated event provides a unique opportunity for over 150 formulation and drug delivery leaders to network and engage in scientific discussions about the most exciting areas of research that will shape the future landscape of the industry.

The formulation and drug delivery market represents a complex area of the industry that is accelerating at a substantial rate. The market’s expansion is the consequence of recent advancements in biologics and small molecule drugs formulation research, advanced solid and liquid formulations strategies and novel drug delivery technologies. A recent survey has also highlighted that the global drug delivery technology market is expected to reach $224.2 billion by 2017.

On day one our highly esteemed speakers will focus on large molecule drugs formulation and small molecule drug delivery. Presentations will cover such key areas of research as ensuring the quality and stability of biologic formulations as well as the formulation of highly potent molecules. Enhancing nanoparticles as drug delivery systems and various small molecule drug delivery technologies will also be addressed.

On day two delegates will have the unique opportunity to join high-level discussions about small molecule drugs formulation and large molecule drug delivery. Our highly acknowledged speakers will explore novel biologics drug delivery systems, viral and non-viral gene delivery systems and new methods to deliver biologics through the blood-brain barrier. Our highly acknowledged speakers will also address novel small molecule formulation strategies, nano-formulations and amorphous solid dispersions.

Oxford Global is proud to announce the inaugural Inhalation & Respiratory Drug Delivery Congress. The event presents a unique opportunity for experts working in the field to look at the development and formulation on inhaled therapies as well as inhalation devices and analytics. Industry leaders will discuss such hot topic areas as achieving an inhaled insulin product, the challenges of developing inhalation devices and analytical tools for inhaled medicines.

The Formulation & Drug Delivery Congress is one of Oxford Global’s highly successful life science events. For more information on other events in this series, please see the details below:


2016 Formulation & Drug Delivery Congress and Inhalation & Respiratory Drug Delivery Congress Sponsors:

2015 Formulation and Drug Delivery Congress Sponsors:


SolutionProviderTestimonial4DelegateTestimonial4SolutionProviderTestimonial3DelegateTestimonial7Keucept.jpgDelegateTestimonial5Raphas 2MSD.jpgSolutionProviderTestimonial2Merck Serano.jpgGSK.jpgDruggability Technologies.jpgSolutionProviderTestimonial5Juniper.jpgDelegateTestimonial1Nanologica.jpgJetpharma 2.jpgDiamond Lightsource.jpgUniversity of Sunderland.jpgDelegateTestimonial3DelegateTestimonial6SolutionProviderTestimonial7Centre National Recherche Scientifique.jpgFreeslate.jpgDelegateTestimonial2SolutionProviderTestimonial8Hemofarm AD.jpgSolutionProviderTestimonial6

Media Partners